- Home
- XBP vs ICCM Comparison
XBP vs ICCM Comparison
Compare XBP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XBP | ICCM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.2M | 43.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | XBP | ICCM |
|---|---|---|
| Price | $7.73 | $0.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 14.4K | ★ 204.3K |
| Earning Date | 03-18-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,823,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.11 | $0.54 |
| 52 Week High | $25.60 | $1.66 |
Technical Indicators
Market Signals| Indicator | XBP | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 36.80 |
| Support Level | $7.50 | $0.59 |
| Resistance Level | $8.34 | $0.62 |
| Average True Range (ATR) | 0.53 | 0.03 |
| MACD | -0.25 | -0.00 |
| Stochastic Oscillator | 0.00 | 25.90 |
Price Performance
Historical ComparisonAbout XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. By combining innovation with execution excellence, XBP Global helps businesses reimagine business process automation and enable digital transformation.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.